Who are DHA-PQP coadministered with PQ's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dha-pqp-coadministered-with-pq.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

DHA-PQP coadministered with PQ — Competitive Intelligence Brief

DHA-PQP coadministered with PQ (DHA-PQP coadministered with PQ) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artemisinin-based combination therapy (ACT) with 8-aminoquinoline. Area: Infectious Disease.

phase 3 Artemisinin-based combination therapy (ACT) with 8-aminoquinoline Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

DHA-PQP coadministered with PQ (DHA-PQP coadministered with PQ) — Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. DHA-PQP (dihydroartemisinin-piperaquine) combined with primaquine works by killing malaria parasites at multiple lifecycle stages, with DHA-PQP targeting blood-stage parasites and primaquine targeting liver-stage and gametocyte forms.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DHA-PQP coadministered with PQ TARGET	DHA-PQP coadministered with PQ	Fundação de Medicina Tropical Dr. Heitor Vieira Dourado	phase 3	Artemisinin-based combination therapy (ACT) with 8-aminoquinoline

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artemisinin-based combination therapy (ACT) with 8-aminoquinoline class)

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DHA-PQP coadministered with PQ — Competitive Intelligence Brief. https://druglandscape.com/ci/dha-pqp-coadministered-with-pq. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab